 Normal healthy subjects |
|
| Healthy elderly subjects |
|
| Diabetes patients, Types I & II |
|
| Hypertensive patients |
|
| Cardiovascular disease patients |
|
| Asthmatic patients |
|
| Patients with peptic ulcer (PUD) and gastroesophageal reflux (GERD) disease |
|
| Obese subjects |
|
| Postmenopausal women |
|
 |
Healthy premenopausal women with regular menstrual cycles with and without oral contraceptives |
| Surgically sterile females |
|
| Hypogonadal males |
|
| Hyperlipemic patients |
|
 |
||
 |
In Phase I / Bioequivalence PharmaNet offers a comprehensive range of clinical development and consulting services for early stage programs, including Phase I and bioequivalence studies. PharmaNet conducts early stage programs for international sponsors through our global network of resources. |
 |
 |
||
Special Populations
PharmaNet Development Group, Inc.
504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390
504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390
© 2008 PharmaNet Development Group, Inc. All rights reserved.